+435.9%
RVMD vs THC
+237.5%
+198.4%
-51.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.2% | -2.9% | +2.6% | +0.5% |
| 7D | -9.6% | -8.1% | -1.5% | -7.6% |
| 30D | -18.9% | -3.2% | -15.7% | -18.3% |
| 3M | -25.7% | -1.8% | -23.9% | -25.5% |
| 6M | +8.2% | +37.7% | -29.5% | -1.8% |
| YTD | +100.2% | +32.6% | +67.5% | +80.8% |
| 1Y | +126.0% | +35.7% | +90.3% | +102.4% |
| 3Y | +647.4% | +313.5% | +333.9% | +334.3% |
| 5Y | +435.9% | +240.3% | +195.6% | +219.2% |
| All | +435.9% | +237.5% | +198.4% | +219.2% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling